Lung cancer treatment waiting times and tumour growth

被引:179
作者
O'Rourke, N
Edwards, R
机构
[1] Univ Glasgow, Western Infirm, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland
[2] Gartnavel Gen Hosp, Glasgow, Lanark, Scotland
关键词
lung cancer; tumour growth; waiting times;
D O I
10.1053/clon.2000.9139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a single-centre prospective audit of 29 lung cancer patients who were awaiting radical (potentially curative) radiotherapy. This was the total number assessed as suitable for radical treatment by one consultant during 1999. At the time of assessment they had been newly diagnosed and staged with a computed tomographic (CT scan of chest. They had a subsequent CT scan prior to starting treatment for the purpose of planning the radiation fields. We have now measured tumour size on the diagnostic scans and compared this with the size on the planning scans. We have documented the delay between diagnostic and planning CT scanning and the total time between first hospital visit and starting treatment. Two patients had progression of symptoms while on the waiting list, making them unfit for radical treatment, and another four had tumour progression on planning CT such that the tumour volume was too large for radical treatment. Therefore, 21% of potentially curable patients became incurable on the waiting list. The delay between diagnostic and planning CT scans ranged from 18 to 131 days (median 54), with increases in the cross-sectional tumour size over that period ranging zero to 373%. The delay between the first hospital visit and starting treatment was 35-187 days (median 94); between the date of the radiotherapy request and the starting date for treatment it was 23-61 days (median 44). Limited access to specialists is the reason most often advanced for the poor performance of the UK in treating lung cancer. This study demonstrates that, even for the select minority of patients who have specialist referral and are deemed suitable for potentially curative treatment, the outcome is prejudiced by waiting times that allow tumour progression.
引用
收藏
页码:141 / 144
页数:4
相关论文
共 7 条
[1]  
Bullimore J A, 1998, Clin Oncol (R Coll Radiol), V10, P210, DOI 10.1016/S0936-6555(98)80002-2
[2]   Improving cancer outcomes through radiotherapy - Lack of UK radiotherapy resources prejudices cancer outcomes [J].
Burnet, NG ;
Benson, RJ ;
Williams, MV ;
Peacock, JH .
BRITISH MEDICAL JOURNAL, 2000, 320 (7229) :198-199
[3]   Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: A report by the CHART Steering Committee [J].
Dische, S ;
Gibson, D ;
Parmar, M ;
Saunders, MI .
THORAX, 1996, 51 (12) :1262-1265
[4]   Variation in survival of patients with lung cancer in Europe, 1985-1989 [J].
Janssen-Heijnen, MLG ;
Gatta, G ;
Forman, D ;
Capocaccia, R ;
Coebergh, JWW .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (14) :2191-2196
[5]  
Joint Council for Clinical Oncology, 1993, RED DEL CANC TREATM
[6]  
*ROYAL COLL RAD, 1998, NAT AUD WAIT TIM RAD
[7]  
*SCOTT CANC THER N, 1998, SCOTT INT GUID NETW